News
04-21-2015, 04:51 AM
ANGLE plc, the specialist medtech company, is delighted to announce that the Medical University of Vienna, one of its key opinion leaders, has published highly encouraging results in support of the use of ANGLE's Parsortix system in the detection of ovarian cancer.
More... (http://www.news-medical.net/news/20150421/Medical-University-of-Vienna-study-supports-use-of-ANGLEs-Parsortix-system-for-ovarian-cancer-study.aspx)
More... (http://www.news-medical.net/news/20150421/Medical-University-of-Vienna-study-supports-use-of-ANGLEs-Parsortix-system-for-ovarian-cancer-study.aspx)